We’re reader-supported and may be paid when you visit links to partner sites. We don’t compare all products in the market, but we’re working on it!
Universal Biosensors Inc is a medical devices business based in Australia. Universal Biosensors shares (UBI) are listed on the Australian Securities Exchange (ASX) and all prices are in Australian Dollars. Universal Biosensors has a trailing 12-month revenue of around $5.5 million. If you're looking to buy shares, check out the steps below.
Our top pick for
US stocks
Our top pick for
ETF investing
Our top pick for
Overall broker
| 52-week range | $0.295 - $0.97 |
|---|---|
| 50-day moving average | $0.8231 |
| 200-day moving average | $0.7548 |
| Target price | $1.39 |
| PE ratio | N/A |
| Dividend yield | N/A (0%) |
| Earnings per share (TTM) | $-0.036 |
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
Historical closes compared with the last close of A$0.785
| 1 week (2021-10-07) | -0.63% |
|---|---|
| 1 month (2021-09-17) | -8.72% |
| 3 months (2021-07-16) | 0.785 |
| 6 months (2021-04-16) | -1.88% |
| 1 year (2020-10-16) | 161.67% |
|---|---|
| 2 years (2019-10-17) | 313.16% |
| 3 years (2018-10-17) | 248.89% |
| 5 years (2016-10-17) | 134.33% |
Valuing Universal Biosensors stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Universal Biosensors's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Universal Biosensors's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $41.9 million (£0.0 million).
The EBITDA is a measure of a Universal Biosensors's overall financial performance and is widely used to measure a its profitability.
| Revenue TTM | $5.5 million |
|---|---|
| Gross profit TTM | $623,086 |
| Return on assets TTM | -11.72% |
| Return on equity TTM | -16.68% |
| Profit margin | -114.36% |
| Book value | 0.196 |
| Market capitalisation | $139.5 million |
TTM: trailing 12 months
We're not expecting Universal Biosensors to pay a dividend over the next 12 months.
Over the last 12 months, Universal Biosensors's shares have ranged in value from as little as $0.295 up to $0.97. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (AU average) beta is 1, while Universal Biosensors's is 1.1227. This would suggest that Universal Biosensors's shares are a little bit more volatile than the average for this exchange and represent, relatively-speaking, a slightly higher risk (but potentially also market-beating returns).
Universal Biosensors, Inc., through its subsidiary, Universal Biosensors Pty Ltd, operates as a biosensors company in Australia. The company focuses on the development, manufacture, and commercialization of point-of-use devices for measuring analytes across various industries. It offers SENTIA Wine Analyzer to test Free Sulphur Dioxide; prothrombin time international normalized ratio coagulation test strips; Sentia Free Sulphite test strips; and coagulation testing and calibration services, as well as distributes Siemens' Xprecia Stride Coagulation Analyzer. The company has a license agreement with LifeScan Global Corporation to develop a biosensor strip and a meter to be used for the detection and monitoring of diabetes in animals. Universal Biosensors, Inc. was incorporated in 2001 and is headquartered in Rowville, Australia.
If you're looking to buy shares from Perth, there are a few options available to you.
Shares in mining giant Rio Tinto are up just 7% in the last 12 months.
Everything we know about the Rocketboots IPO, plus information on how to buy in.
Everything we know about the Winsome Resources IPO, plus information on how to buy in.
Get up to 35% off from these Adore Beauty discount codes, Australia’s leading online-only beauty and cosmetics store offering great products for men and women.
Shares in the trans-Tasman dairy company are down 55% over the last 12 months.
Shares in the Brisbane-based lender have risen nearly 60% in the last 12 months.
Everything we know about the Tissue Repair IPO, plus information on how to buy in.
This guide will show you step-by-step instructions on how to buy the Illuvium (ILV) token as well as a list of exchanges you can trade it on.
Westpac shares are up 43% over the past 12 months.
